FIA
TXG icon

Foundations Investment Advisors’s 10x Genomics TXG Stock Holding History

Foundations Investment Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Buy
+41,989
New +$1.1M 0.02% 459
2026
Q1 		– Sell
-45,185
Closed -$737K – 1250
2025
Q4 		$737K Sell
45,185
-11,721
-21% -$177K 0.01% 592
2025
Q3 		$665K Buy
+56,906
New +$742K 0.01% 579

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Foundations Investment Advisors's TXG Position: Q2 2026 in Review

Foundations Investment Advisors opened a new position in 10x Genomics (TXG) in Q2 2026: 41,989 shares worth $1.61M. The stake represents 0.02% of the portfolio and ranks #459 among its holdings. This is a return to the name: Foundations Investment Advisors previously reported a position in TXG as recently as Q4 2025.

Foundations Investment Advisors first reported a position in TXG in Q3 2025 and has held it in 3 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Foundations Investment Advisors held 41,989 shares of 10x Genomics worth $1.61M as of Q2 2026.
  • 10x Genomics was a new Foundations Investment Advisors position in Q2 2026.
  • 10x Genomics made up 0.02% of Foundations Investment Advisors's portfolio in Q2 2026, its #459 holding.
  • Foundations Investment Advisors first reported a position in 10x Genomics in Q3 2025 and has held it in 3 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.